4 November 2024
Exentis is breaking new ground in Additive Manufacturing. The unique and extensively patented Exentis additive screen printing technology enables the mass production of millions of components with complex geometries. With this development, the Swiss company is opening up new applications to production companies in industry, the pharmaceutical sector, and other sectors.
Exentis 3D Mass Customization Technology is a sustainable AM cold printing process. The material is efficiently applied layer by layer as a paste through screens. Geometry changes can be made quickly and flexibly using new screens. The Swiss company’s production systems are modular and can be flexibly configured for industrial and cleanroom applications. They can produce very small components with ultra-fine structures of up to 125 µm channel width, as well as larger components with a diameter of up to 400 mm.
High building rate and surface quality
For industrial applications, additional features such as cooling structures or integrated channels can be processed in a single step. If structures of this complexity could be produced using conventional manufacturing methods, several individual steps would be required. A wide range of materials can be used in the process. All available powdered materials such as ceramics, metals, polymers, active pharmaceutical ingredients, and biomaterials are processed into a printable paste, which is then used to manufacture the components.
In contrast to other AM processes, the Exentis technology’s building rate of up to 10,000 cm3/h and a production volume of more than 5 million components per system per year enables “genuine large-scale production”. This is combined with Exentis technology’s great design freedom and a surface quality of Ra 2 micrometers, which is exceptional for additive manufacturing.
Up to four different active ingredients in one tablet
The pharmaceutical industry is another important area of application for Exentis technology. An Exentis production system can manufacture over 200 million tablets per year. Thanks to the EX434 iflex GMP production system’s four printing towers, several different active pharmaceutical ingredients can be individually processed in a single step. Production can also be converted to handle other active ingredients within a very short time, as there is no powder dust contamination, when using pastes.
Exentis’s innovative systems are already being used successfully in numerous countries around the world. The up-and-coming high-tech company with headquarters in Stetten, Switzerland, employs 130 people and offers a comprehensive all-in-one service, including production systems, component development projects, materials and services, as well as contract manufacturing.
FURTHER INFORMATION:
Exentis at Formnext 2024: Hall 11, Booth C62
Tags
- Additive Manufacturing